Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3155 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approves Lannett’s dipyridamole tablets

Dipyridamole Tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement. Arthur Bedrosian, president and CEO of Lannett,

FDA approves once-a-month dose of Actonel

Actonel is approved to reduce the risk of fractures in postmenopausal women with osteoporosis. The FDA approval of the once-a-month dose is based on a study comparing Actonel

Amneal to acquire assets of Interpharm

Amneal has said it will use its leadership and financial position to fully realize the potential of Interpharm’s product line, ensure approval of its development pipeline and leverage